Evidence map›Paper›PMID 27384655›Full record

ArticleJournal of virology2016

Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability.

Matteo Biolatti, Valentina Dell'Oste, Sara Pautasso, Jens von Einem, Manfred Marschall, Bodo Plachter, Marisa Gariglio, Marco De Andrea, Santo Landolfo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Matteo BiolattiDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7675-0762
Valentina Dell'OsteDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-9336-7906
Sara PautassoDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
Jens von EinemInstitute of Virology, University Hospital Ulm, Ulm, Germany.
Manfred MarschallInstitute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Bodo PlachterInstitute for Virology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Marisa GariglioDepartment of Translational Medicine, Novara Medical School, Novara, Italy.ORCID 0000-0002-5187-0140
Marco De AndreaDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy Department of Translational Medicine, Novara Medical School, Novara, Italy.ORCID 0000-0002-3188-5783
Santo LandolfoDepartment of Public Health and Pediatric Sciences, University of Turin, Turin, Italy santo.landolfo@unito.it.ORCID 0000-0002-3153-2865
University of Turin · ITFriedrich-Alexander-Universität Erlangen-Nürnberg · DEJohannes Gutenberg University Mainz · DEUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledA key player in the intrinsic resistance against human cytomegalovirus (HCMV) is the interferon-γ-inducible protein 16 (IFI16), which behaves as a viral DNA sensor in the first hours postinfection and as a repressor of viral gene transcription in the later stages. Previous studies on HCMV replication demonstrated that IFI16 binds to the viral protein kinase pUL97, undergoes phosphorylation, and relocalizes to the cytoplasm of infected cells. In this study, we demonstrate that the tegument protein pp65 (pUL83) recruits IFI16 to the promoter of the UL54 gene and downregulates viral replication, as shown by use of the HCMV mutant v65Stop, which lacks pp65 expression. Interestingly, at late time points of HCMV infection, IFI16 is stabilized by its interaction with pp65, which stood in contrast to IFI16 degradation, observed in herpes simplex virus 1 (HSV-1)-infected cells. Moreover, we found that its translocation to the cytoplasm, in addition to pUL97, strictly depends on pp65, as demonstrated with the HCMV mutant RV-VM1, which expresses a form of pp65 unable to translocate into the cytoplasm. Thus, these data reveal a dual role for pp65: during early infection, it modulates IFI16 activity at the promoter of immediate-early and early genes; subsequently, it delocalizes IFI16 from the nucleus into the cytoplasm, thereby stabilizing and protecting it from degradation. Overall, these data identify a novel activity of the pp65/IFI16 interactome involved in the regulation of UL54 gene expression and IFI16 stability during early and late phases of HCMV replication. IMPORTANCE: The DNA sensor IFI16, a member of the PYHIN proteins, restricts HCMV replication by impairing viral DNA synthesis. Using a mutant virus lacking the tegument protein pp65 (v65Stop), we demonstrate that pp65 recruits IFI16 to the early UL54 gene promoter. As a putative counteraction to its restriction activity, pp65 supports the nucleocytoplasmic export of IFI16, which was demonstrated with the viral mutant RV-VM1 expressing a nuclearly retained pp65. These data reveal a dual role of pp65 in IFI16 regulation: in the early phase of HCMV infection, it contributes to viral evasion from IFI16 restriction activity, while at later time points, it promotes the nuclear delocalization of IFI16, thereby stabilizing and protecting it from degradation. In the present work, we further clarify the mechanisms HCMV relies on to overcome intracellular innate immune restriction and provide new insights into the relevance of DNA-sensing restriction factor IFI16 during HCMV infection.

Indexed as

Host-Pathogen InteractionsVirus ReplicationCells, CulturedCytomegalovirusDNA-Directed DNA PolymeraseDNA, ViralHumansNuclear ProteinsPhosphoproteinsPromoter Regions, GeneticProtein BindingProtein StabilityViral Matrix ProteinsViral Proteinscytomegalovirus matrix protein 65kDaDNA-Directed DNA PolymeraseDNA, ViralIFI16 protein, humanNuclear ProteinsPhosphoproteinsUL54 protein, Human herpesvirus 5Viral Matrix ProteinsViral Proteins

Identifiers

PMID27384655
PMCPMC5008087
OpenAlexW2462745461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.